News

Recent news about Panacea Capital and select portfolio companies

February 26, 2026

Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome

February 26, 2026

Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome

February 10, 2026

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

February 10, 2026

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

February 10, 2026

Kainova Therapeutics secures $CAD 32 million to accelerate the development of its immuno-oncology and inflammation portfolio.

February 10, 2026

Kainova Therapeutics secures $CAD 32 million to accelerate the development of its immuno-oncology and inflammation portfolio.

January 30, 2026

HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development

Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…

January 30, 2026

HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development

Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…

January 30, 2026

US FDA Regulatory Meetings

Understanding the various types of regulatory meetings available with the US FDA is crucial for…

January 30, 2026

US FDA Regulatory Meetings

Understanding the various types of regulatory meetings available with the US FDA is crucial for…